Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Providigm is a U.S. healthcare technology company focused on quality assurance and performance improvement for post-acute and long-term care providers, especially skilled nursing facilities. Its core product, abaqis, is a SaaS-based quality management and survey-readiness platform designed to help facilities identify risks, improve care quality, and prepare for regulatory surveys. The company combines clinical, scientific, and information technology capabilities to support quality, compliance, and workforce improvement in nursing care settings. Providigm was acquired by HealthStream in January 2019 for $18 million and has since operated as part of HealthStream's healthcare workforce and quality solutions portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Providigm.